AMHD — HLK Biotec Holding Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.41m
Annual cashflow statement for HLK Biotec Holding, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
1998 June 30th | 1999 June 30th | |
|---|---|---|
| Period Length: | 1 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -0.08 | -1.04 |
| Depreciation | ||
| Non-Cash Items | 0.005 | 0.323 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.039 | 0.267 |
| Change in Prepaid Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Cash from Operating Activities | -0.114 | -0.442 |
| Other Investing Cash Flow Items | 0 | -0.312 |
| Acquisition of Business | ||
| Change in Net Investments | ||
| Other Investing Cash Flow | ||
| Cash from Investing Activities | 0 | -0.312 |
| Financing Cash Flow Items | 0.015 | -0.064 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 0.115 | 0.816 |
| Net Change in Cash | 0.001 | 0.063 |